California-based contract research organisation PRC Clinical has made several management and executive appointments to its team.
Tony Taricco (pictured), co-founder and current chief operations officer has been named as president and chairman of the board of directors. Taricco co-founded PRC Clinical in 2003 and previously spent 20 years in workers compensation insurance.
Daniel Head has been appointed as VP of business operations, bringing over 20 years of experience in growing profitable businesses based on strategy and strategic alliances. Head will additionally lead the new East Coast business development office.
Regarding the new office, CEO at PRC Clinical Curtis Head commented: “This is a significant step forward for PRC Clinical, one that gives us better geographic reach and convenience for out clients both nationally and internationally.”
Mike Catelani will assume the role of chief financial officer and member of the board of directors, bringing with him over 25 years of finance and accounting experience. Catelani was previously founder, president and CFO at Tacere Therapeutics.
Sue Dowden joins as senior director of clinical operations. Dowden has over 25 years of clinical research experience and has held positions of increasing responsibility including all aspects of clinical research, data monitoring and project management.
Commenting on Dowden’s appointment, Taricco said: “Sue’s proven track record working with sponsors and CROs gives PRC a unique advantage for customer satisfaction, quality assurance and successful trial management.”